Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 432, 263 (18 November 2004) | doi:10.1038/432263b; Published online 17 November 2004
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
- More Challenges
- Powered by:
nature jobs
Senior DMPK scientist
- Cancer Research Technology (CRT)
- London, United Kingdom
International PhD Programme
- MRC Laboratory of Molecular Biology
- Cambridge, UK
Britain to combat conflicts of interest in drug regulators
Jim Giles
Tough measures designed to excise conflicts of interest from committees that regulate drugs have been proposed by the British government.If the proposals are accepted, advisers on the panels that assess drug safety and performance, and report to the Medicines and Healthcare products Regulatory Agency (MHRA), will have to relinquish all financial interests in the pharmaceutical industry, health minister Norman Warner said on 11 November.
To read this story in full you will need to login or make a payment (see right).
